124 related articles for article (PubMed ID: 28807337)
21. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
[TBL] [Abstract][Full Text] [Related]
22. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
23. Chromogenic immunohistochemical quadruplex provides accurate diagnostic differentiation of non-small cell lung cancer.
Roberts EA; Morrison LE; Behman LJ; Draganova-Tacheva R; O'Neill R; Solomides CC
Ann Diagn Pathol; 2020 Apr; 45():151454. PubMed ID: 31923744
[TBL] [Abstract][Full Text] [Related]
24. Assessment of CD43 expression in adenoid cystic carcinomas, polymorphous low-grade adenocarcinomas, and monomorphic adenomas.
Woo VL; Bhuiya T; Kelsch R
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):495-500. PubMed ID: 16997117
[TBL] [Abstract][Full Text] [Related]
25. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
McCluggage WG; Kennedy K; Busam KJ
Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
[TBL] [Abstract][Full Text] [Related]
26. Utility of 123C3 monoclonal antibody against CD56 (NCAM) for the diagnosis of small cell carcinomas on paraffin sections.
Kaufmann O; Georgi T; Dietel M
Hum Pathol; 1997 Dec; 28(12):1373-8. PubMed ID: 9416693
[TBL] [Abstract][Full Text] [Related]
27. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
Oliva E; Amin MB; Jimenez R; Young RH
Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
[TBL] [Abstract][Full Text] [Related]
28. Expression of neuroendocrine markers in non-neuroendocrine endometrial carcinomas.
Moritz AW; Schlumbrecht MP; Nadji M; Pinto A
Pathology; 2019 Jun; 51(4):369-374. PubMed ID: 31040050
[TBL] [Abstract][Full Text] [Related]
29. Utility of TRPS1 immunohistochemistry in confirming breast carcinoma: Emphasis on staining in triple-negative breast cancers and gynecologic tumors.
Rammal R; Goel K; Elishaev E; Soong TR; Jones MW; Zhao C; Clark BZ; Carter GJ; Yu J; Fine JL; Villatoro TM; Skvarca L; Harinath L; Bhargava R
Am J Clin Pathol; 2023 Oct; 160(4):425-434. PubMed ID: 37352847
[TBL] [Abstract][Full Text] [Related]
30. Abnormal expression of LCA and CD43 in SCLC: a rare case report and brief literature review.
Cai Z; Zuo L; Hu F; You H; Lu X; Liao S; Liu F; Li L; Huang W
BMC Pulm Med; 2024 Apr; 24(1):195. PubMed ID: 38649942
[TBL] [Abstract][Full Text] [Related]
31. IMP3 expression is correlated with histologic grade of lung adenocarcinoma.
Findeis-Hosey JJ; Yang Q; Spaulding BO; Wang HL; Xu H
Hum Pathol; 2010 Apr; 41(4):477-84. PubMed ID: 20004948
[TBL] [Abstract][Full Text] [Related]
32. Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B-cell lymphoma.
Ma XB; Zhong YP; Zheng Y; Jiang J; Wang YP
Cancer Med; 2018 Sep; 7(9):4284-4295. PubMed ID: 30019388
[TBL] [Abstract][Full Text] [Related]
33. Promyelocytic leukemia zinc finger and histone H1.5 differentially stain low- and high-grade pulmonary neuroendocrine tumors: a pilot immunohistochemical study.
Hechtman JF; Beasley MB; Kinoshita Y; Ko HM; Hao K; Burstein DE
Hum Pathol; 2013 Jul; 44(7):1400-5. PubMed ID: 23416030
[TBL] [Abstract][Full Text] [Related]
34. Utility of monoclonal PAX8 antibody for distinguishing intrathyroid thymic carcinoma from follicular cell-derived thyroid carcinoma.
Suzuki A; Hirokawa M; Takada N; Higuchi M; Tanaka A; Hayashi T; Kuma S; Miyauchi A
Endocr J; 2018 Dec; 65(12):1171-1175. PubMed ID: 30210064
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical p16INK4a analysis of archival tumors with deletion, hypermethylation, or mutation of the CDKN2/MTS1 gene. A comparison of four commercial antibodies.
Geradts J; Hruban RH; Schutte M; Kern SE; Maynard R
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):71-9. PubMed ID: 10937052
[TBL] [Abstract][Full Text] [Related]
36. Leukocyte marker CD43 promotes cell growth in co-operation with β-catenin in non-hematopoietic cancer cells.
Balikova A; Jääger K; Viil J; Maimets T; Kadaja-Saarepuu L
Int J Oncol; 2012 Jul; 41(1):299-309. PubMed ID: 22576689
[TBL] [Abstract][Full Text] [Related]
37. cMYC expression in thyroid follicular cell-derived carcinomas: a role in thyroid tumorigenesis.
Sakr HI; Chute DJ; Nasr C; Sturgis CD
Diagn Pathol; 2017 Oct; 12(1):71. PubMed ID: 28974238
[TBL] [Abstract][Full Text] [Related]
38. CD43 promotes cell growth and helps to evade FAS-mediated apoptosis in non-hematopoietic cancer cells lacking the tumor suppressors p53 or ARF.
Kadaja-Saarepuu L; Laos S; Jääger K; Viil J; Balikova A; Lõoke M; Hansson GC; Maimets T
Oncogene; 2008 Mar; 27(12):1705-15. PubMed ID: 17891181
[TBL] [Abstract][Full Text] [Related]
39. Identification of metastatic papillary thyroid carcinoma in FNA specimens using thyroid peroxidase immunohistochemistry.
Shield PW; Crouch SJ; Papadimos DJ; Walsh MD
Cytopathology; 2018 Jun; 29(3):227-232. PubMed ID: 29508480
[TBL] [Abstract][Full Text] [Related]
40. Epithelial membrane antigen--a diagnostic discriminant in surgical pathology: immunohistochemical profile in epithelial, mesenchymal, and hematopoietic neoplasms using paraffin sections and monoclonal antibodies.
Pinkus GS; Kurtin PJ
Hum Pathol; 1985 Sep; 16(9):929-40. PubMed ID: 2993153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
